GPR56 activators are an array of chemical compounds that enhance the signaling efficacy of the G protein-coupled receptor 56 (GPR56), an adhesion G protein-coupled receptor involved in a multitude of physiological processes. These activators work through various biochemical mechanisms to amplify the signaling cascade initiated by GPR56 binding to its ligands. For instance, some of these chemicals might influence the receptor's conformation or interaction with its associated G proteins, thereby enhancing GPR56's responsiveness to its natural ligands. Others may increase the affinity of GPR56 for its ligands, leading to a more robust cellular response upon ligand binding. Some activators operate by upregulating the expression of GPR56 on the cell surface, providing more receptors available for activation. These compounds are characterized by their specificity in targeting GPR56 without broadly impacting other G protein-coupled receptors, ensuring that the amplification of signaling is confined to the pathways where GPR56 is a critical mediator.
The activation of GPR56 by these chemical agents can lead to a cascade of intracellular events, including the activation of downstream effector proteins and second messengers that propagate the signal to elicit specific cellular responses. The biochemical pathways influenced by GPR56 include those regulating cell adhesion, migration, and possibly differentiation, given the receptor's expression pattern and involvement in developmental processes. GPR56 activators may enhance the receptor's interaction with its intracellular partners, such as G proteins and beta-arrestins, to modulate the receptor's signaling output. By facilitating these interactions, the activators ensure that the cell's response to extracellular cues is appropriately amplified. The precise mechanisms by which these activators exert their effects on GPR56 signaling are the subject of ongoing research, and their elucidation will deepen the understanding of the intricate web of cellular communication networks in which GPR56 is entwined.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Lysophosphatidic acid acts on its receptors which are G protein-coupled, similar to GPR56, enhancing GPR56 signaling through shared G protein pathways. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
DHA, an omega-3 fatty acid, may influence GPR56 activity through alteration of membrane fluidity and receptor conformation, leading to enhanced signaling. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
FTY720 is a sphingosine analog that modulates sphingosine-1-phosphate receptors, potentially cross-activating GPR56 through related G protein-coupled receptor pathways. | ||||||